BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30176814)

  • 1. Relationship between the Ki67 index and its area based approximation in breast cancer.
    Niazi MKK; Senaras C; Pennell M; Arole V; Tozbikian G; Gurcan MN
    BMC Cancer; 2018 Sep; 18(1):867. PubMed ID: 30176814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Digital image analysis of Ki67 proliferation index in breast cancer using virtual dual staining on whole tissue sections: clinical validation and inter-platform agreement.
    Koopman T; Buikema HJ; Hollema H; de Bock GH; van der Vegt B
    Breast Cancer Res Treat; 2018 May; 169(1):33-42. PubMed ID: 29349710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality assessment of Ki67 staining using cell line proliferation index and stain intensity features.
    Lanng MB; Møller CB; Andersen AH; Pálsdóttir ÁA; Røge R; Østergaard LR; Jørgensen AS
    Cytometry A; 2019 Apr; 95(4):381-388. PubMed ID: 30556331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An international multicenter study to evaluate reproducibility of automated scoring for assessment of Ki67 in breast cancer.
    Rimm DL; Leung SCY; McShane LM; Bai Y; Bane AL; Bartlett JMS; Bayani J; Chang MC; Dean M; Denkert C; Enwere EK; Galderisi C; Gholap A; Hugh JC; Jadhav A; Kornaga EN; Laurinavicius A; Levenson R; Lima J; Miller K; Pantanowitz L; Piper T; Ruan J; Srinivasan M; Virk S; Wu Y; Yang H; Hayes DF; Nielsen TO; Dowsett M
    Mod Pathol; 2019 Jan; 32(1):59-69. PubMed ID: 30143750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A methodology to ensure and improve accuracy of Ki67 labelling index estimation by automated digital image analysis in breast cancer tissue.
    Laurinavicius A; Plancoulaine B; Laurinaviciene A; Herlin P; Meskauskas R; Baltrusaityte I; Besusparis J; Dasevicius D; Elie N; Iqbal Y; Bor C
    Breast Cancer Res; 2014; 16(2):R35. PubMed ID: 24708745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standardized Ki67 Diagnostics Using Automated Scoring--Clinical Validation in the GeparTrio Breast Cancer Study.
    Klauschen F; Wienert S; Schmitt WD; Loibl S; Gerber B; Blohmer JU; Huober J; Rüdiger T; Erbstößer E; Mehta K; Lederer B; Dietel M; Denkert C; von Minckwitz G
    Clin Cancer Res; 2015 Aug; 21(16):3651-7. PubMed ID: 25501130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of tissue sampling on accuracy of Ki67 immunohistochemistry evaluation in breast cancer.
    Besusparis J; Plancoulaine B; Rasmusson A; Augulis R; Green AR; Ellis IO; Laurinaviciene A; Herlin P; Laurinavicius A
    Diagn Pathol; 2016 Aug; 11(1):82. PubMed ID: 27576949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proliferation Tumour Marker Network (PTM-NET) for the identification of tumour region in Ki67 stained breast cancer whole slide images.
    Joseph J; Roudier MP; Narayanan PL; Augulis R; Ros VR; Pritchard A; Gerrard J; Laurinavicius A; Harrington EA; Barrett JC; Howat WJ
    Sci Rep; 2019 Sep; 9(1):12845. PubMed ID: 31492872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Automated characterization and counting of Ki-67 protein for breast cancer prognosis: A quantitative immunohistochemistry approach.
    Mungle T; Tewary S; Arun I; Basak B; Agarwal S; Ahmed R; Chatterjee S; Maity AK; Chakraborty C
    Comput Methods Programs Biomed; 2017 Feb; 139():149-161. PubMed ID: 28187885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ki67 levels as predictive and prognostic parameters in pretherapeutic breast cancer core biopsies: a translational investigation in the neoadjuvant GeparTrio trial.
    Denkert C; Loibl S; Müller BM; Eidtmann H; Schmitt WD; Eiermann W; Gerber B; Tesch H; Hilfrich J; Huober J; Fehm T; Barinoff J; Jackisch C; Prinzler J; Rüdiger T; Erbstösser E; Blohmer JU; Budczies J; Mehta KM; von Minckwitz G
    Ann Oncol; 2013 Nov; 24(11):2786-93. PubMed ID: 23970015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A simple digital image analysis system for automated Ki67 assessment in primary breast cancer.
    Alataki A; Zabaglo L; Tovey H; Dodson A; Dowsett M
    Histopathology; 2021 Aug; 79(2):200-209. PubMed ID: 33590538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of automated Ki67 analysis to predict Oncotype DX risk-of-recurrence categories in early-stage breast cancer.
    Thakur SS; Li H; Chan AMY; Tudor R; Bigras G; Morris D; Enwere EK; Yang H
    PLoS One; 2018; 13(1):e0188983. PubMed ID: 29304138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantum dots-based quantitative and in situ multiple imaging on ki67 and cytokeratin to improve ki67 assessment in breast cancer.
    Yuan JP; Wang LW; Qu AP; Chen JM; Xiang QM; Chen C; Sun SR; Pang DW; Liu J; Li Y
    PLoS One; 2015; 10(4):e0122734. PubMed ID: 25856425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An adaptive positivity thresholding method for automated Ki67 hotspot detection (AKHoD) in breast cancer biopsies.
    Pilutti D; Della Mea V; Pegolo E; La Marra F; Antoniazzi F; Di Loreto C
    Comput Med Imaging Graph; 2017 Nov; 61():28-34. PubMed ID: 28499621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of Oncotype Dx score with tumor grade, size, nodal status, proliferative marker Ki67 and Nottingham Prognostic Index in early breast cancer tumors in Saudi Population.
    Durrani S; Al-Mushawa F; Heena H; Wani T; Al-Qahtani A
    Ann Diagn Pathol; 2021 Apr; 51():151674. PubMed ID: 33360027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bimodality of intratumor Ki67 expression is an independent prognostic factor of overall survival in patients with invasive breast carcinoma.
    Laurinavicius A; Plancoulaine B; Rasmusson A; Besusparis J; Augulis R; Meskauskas R; Herlin P; Laurinaviciene A; Abdelhadi Muftah AA; Miligy I; Aleskandarany M; Rakha EA; Green AR; Ellis IO
    Virchows Arch; 2016 Apr; 468(4):493-502. PubMed ID: 26818835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ki67 index in intrinsic breast cancer subtypes and its association with prognostic parameters.
    Hashmi AA; Hashmi KA; Irfan M; Khan SM; Edhi MM; Ali JP; Hashmi SK; Asif H; Faridi N; Khan A
    BMC Res Notes; 2019 Sep; 12(1):605. PubMed ID: 31547858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Automated quantitative analysis of Ki-67 staining and HE images recognition and registration based on whole tissue sections in breast carcinoma.
    Feng M; Deng Y; Yang L; Jing Q; Zhang Z; Xu L; Wei X; Zhou Y; Wu D; Xiang F; Wang Y; Bao J; Bu H
    Diagn Pathol; 2020 May; 15(1):65. PubMed ID: 32471471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An international study to increase concordance in Ki67 scoring.
    Polley MY; Leung SC; Gao D; Mastropasqua MG; Zabaglo LA; Bartlett JM; McShane LM; Enos RA; Badve SS; Bane AL; Borgquist S; Fineberg S; Lin MG; Gown AM; Grabau D; Gutierrez C; Hugh JC; Moriya T; Ohi Y; Osborne CK; Penault-Llorca FM; Piper T; Porter PL; Sakatani T; Salgado R; Starczynski J; Lænkholm AV; Viale G; Dowsett M; Hayes DF; Nielsen TO
    Mod Pathol; 2015 Jun; 28(6):778-86. PubMed ID: 25698062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reliability of Ki67 visual scoring app compared to eyeball estimate and digital image analysis and its prognostic significance in hormone receptor-positive breast cancer.
    Arun I; Venkatesh S; Ahmed R; Agrawal SK; Leung SCY
    APMIS; 2021 Aug; 129(8):489-502. PubMed ID: 34053140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.